BiotechTube
Home/Agenus/Garo H. Armen, PhD
GH

Garo H. Armen, PhD

Founder, Chairman and Chief Executive Officer

Agenus

Therapeutic Areas

Oncology

Agenus Pipeline

DrugIndicationPhase
Botensilimab + BalstilimabMSS Colorectal Cancer (Chemo-refractory, Unresectable)Phase 3
MK-4830 (anti-ILT4)Advanced Solid Tumors (combo)Phase 1/2
INCAGN2390 (anti-TIM-3)Melanoma, SCCHN (triple combo)Phase 1/2
INCAGN2385 (anti-LAG-3)Melanoma, SCCHN (triple combo)Phase 1/2
CR6086 + BalstilimabpMMR-MSS Colorectal CancerPhase 1/2
AGEN1571 (anti-ILT2)Not specifiedNot specified
AGEN1777Not specifiedNot specified
AGEN1721Not specifiedNot specified

Leadership Team at Agenus

UW
Ulf Wiinberg
Board Advisor
LN
Larry Norton, MD
Senior Clinical Advisor
TY
Todd Yancey, MD
Chief Strategic Advisor
View full Agenus profile